New study aims to help older breast cancer patients cope with treatment side effects
NCT ID NCT07232056
First seen Jun 25, 2026 · Last updated Jul 30, 2026 · Updated 3 times
Summary
This study tests two support programs for women aged 65 and older with hormone-sensitive breast cancer who are taking aromatase inhibitors. The programs include a clinic-level geriatric assessment and support, and a telehealth coping skills training based on cognitive behavioral therapy. The goal is to reduce pain and improve quality of life. The trial plans to enroll 452 participants across multiple sites.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Geriatric oncology assessment and support program (GOAL-AI) and CBT-based coping skills training (CST-AI)
- What this could lead to
- If successful, these programs could provide a practical way to reduce pain and improve daily life for older women on hormone therapy.
- What could go wrong
- This is a behavioral intervention trial, so results depend on participant engagement and may not apply to all patients. The study has not yet started recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER, HORMONE RECEPTOR POSITIVE, AROMATASE INHIBITOR-ASSOCIATED ARTHRALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.